PetMed Express Files 8-K/A Amendment

Ticker: PETS · Form: 8-K/A · Filed: 2025-12-29T00:00:00.000Z

Sentiment: neutral

Topics: auditor-change, amendment, financial-reporting

TL;DR

PetMed Express amended its 8-K filing, changing its auditor. Keep an eye on financial statements.

AI Summary

PetMed Express, Inc. filed an amendment (8-K/A) on December 29, 2025, to its report originally filed on December 8, 2025. This amendment pertains to changes in the registrant's certifying accountant and includes financial statements and exhibits. The company is incorporated in Florida and its principal executive offices are located at 420 South Congress Avenue, Delray Beach, Florida.

Why It Matters

This filing indicates a change in PetMed Express's certifying accountant, which could signal potential issues with previous audits or a strategic shift in financial oversight.

Risk Assessment

Risk Level: medium — A change in certifying accountant can sometimes precede or indicate underlying financial or accounting concerns.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K/A filing?

The primary purpose of this 8-K/A filing is to amend the previous report to disclose changes in the registrant's certifying accountant and to include financial statements and exhibits.

When was the original report filed, and when was the amendment filed?

The original report was filed on December 8, 2025, and the amendment (8-K/A) was filed on December 29, 2025.

What is the company's principal executive office address?

The company's principal executive office is located at 420 South Congress Avenue, Delray Beach, Florida 33445.

In which state is PetMed Express, Inc. incorporated?

PetMed Express, Inc. is incorporated in Florida.

What is the SEC file number for PetMed Express, Inc.?

The SEC file number for PetMed Express, Inc. is 001-42429.

From the Filing

0001040130-25-000112.txt : 20251229 0001040130-25-000112.hdr.sgml : 20251229 20251229160846 ACCESSION NUMBER: 0001040130-25-000112 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20251208 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251229 DATE AS OF CHANGE: 20251229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-42429 FILM NUMBER: 251609237 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K/A 1 pets-20251208.htm 8-K/A pets-20251208 0001040130 FALSE 0001040130 2025-12-08 2025-12-08 0001040130 us-gaap:CommonStockMember 2025-12-08 2025-12-08 0001040130 us-gaap:PreferredStockMember 2025-12-08 2025-12-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K/A (Amendment No.1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  December 8, 2025 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Preferred Stock Purchase Rights N/A NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Explanatory Note On December 8, 2025, PetMed Express, Inc. (the “Company”) previously filed a Current Report on Form 8-K (the “Original 8-K”) with the Securities and Exchange Commission (“SEC”) to report that, on December 8, 2025, the Audit Committee of the Board of Directors of the Company had approved (i) the dismissal of RSM US LLP (“RSM”) as the Company’s independent registered public accounting firm, effective upon completion of the interim review of the quarterly information on Form 10-Q for the three months ended June 30, 2025, and September 30, 2025 and (ii) the selection of Baker Tilly US, LLP (“Bake

View on Read The Filing